Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 26, 2026
Synopsys (SNPS) Stock Slides -17.8% Over 30 Days: Drivers Behind the Move and What Comes Next

Synopsys (SNPS) Stock Slides -17.8% Over 30 Days: Drivers Behind the Move and What Comes Next

Key Takeaways

  • Synopsys shares fell approximately 17.8% over the last 30 days, dropping from $454.34 on June 26 to $373.47 by July 24, amid a confluence of company-specific and broader market headwinds.
  • A May 27 earnings beat-and-raise paradoxically fueled the selloff, as investors interpreted restrained full-year guidance and decelerating IP licensing growth as cautionary signals.
  • The company's July decision to sunset legacy manufacturing process-control software, while strategically refocusing on AI-driven design tools, introduced near-term uncertainty among major chipmaker clients.
  • A broad semiconductor selloff on July 17 accelerated losses, with SNPS shedding 7.9% in a single session alongside a 2.2% Nasdaq decline.
  • Analyst consensus remains a "Moderate Buy" with an average price target of approximately $570, implying significant upside from current levels, though technical indicators signal deeply oversold conditions.
  • Over the broader quarter, the stock has retreated markedly from the mid-$490s range as the market continues to reassess Synopsys' post-Ansys acquisition growth and margin trajectory.

Synopsys Company Overview and Market Position

Synopsys, Inc. is a dominant provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify, and manufacture integrated circuits and complex systems-on-chip (SoCs). Its tools enable chipmakers to simulate, synthesize, and validate increasingly complex architectures before production begins. The company occupies a near-duopoly position in EDA alongside Cadence Design Systems, with deep integration into customer workflows that create substantial switching costs. The completed $35 billion acquisition of Ansys in late 2024 expanded Synopsys' reach into multiphysics simulation spanning structural, fluid, thermal, and electromagnetic analysis, broadening its addressable market well beyond chip design into automotive, aerospace, and industrial applications. With a market capitalization of approximately $71.5 billion and institutional ownership exceeding 85%, Synopsys is closely watched by investors as a bellwether for semiconductor R&D spending and AI infrastructure demand.

SNPS Stock Price Performance: Last 30 Days vs. the Quarter

Over the last 30 calendar days, SNPS declined from a closing price of $454.34 on June 26 to $373.47 on July 24, representing a decline of approximately 17.8%. The descent was not gradual; the stock experienced an accelerating selloff through mid-July, punctuated by a 7.9% single-day plunge on July 17 when shares dropped from $417.03 to $384.24. By late July, SNPS was trading roughly 41% below its 52-week high of $651.73 reached in July 2025, with the Relative Strength Index falling to deeply oversold territory near 22.5.

The quarterly picture is similarly stark. From trading around the $495–$500 range in late May following the company's fiscal Q2 earnings release, the stock has steadily deteriorated. The 50-day moving average sits at approximately $456, while the 200-day moving average hovers near $455 — both significantly above the current trading price, indicating sustained technical weakness. The stock's trajectory over the quarter reflects a market that has progressively repriced Synopsys as integration costs, margin concerns, and strategic repositioning have weighed on investor conviction.

What Drove SNPS Stock Price in the Last 30 Days

Multiple catalysts converged to drive Synopsys lower over the past month. The most significant originated with the company's fiscal Q2 2026 earnings report on May 27, where revenue of $2.28 billion and non-GAAP EPS of $3.35 both exceeded consensus estimates. Despite the headline beat, management's decision to raise full-year guidance only to roughly the midpoint of analyst expectations — rather than delivering a more aggressive upward revision — was interpreted as a signal of caution around second-half demand. Investors zeroed in on decelerating growth in the high-margin IP licensing business, which carries disproportionate weight in Synopsys' profitability profile. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

In early July, Reuters reported that Synopsys had informed over a dozen major semiconductor manufacturers — including Samsung Electronics, SK Hynix, Kioxia, and Qorvo — that it would discontinue a portfolio of legacy manufacturing process-control software products. While the company framed this as a strategic reallocation toward higher-margin AI-driven design tools, the announcement introduced near-term execution uncertainty and raised questions about potential revenue disruption.

A broad-based semiconductor selloff on July 17 compounded the pressure, with the Nasdaq falling 2.22% as investors rotated out of concentrated AI and technology positions. SNPS was caught in the downdraft, shedding nearly 8% in a single session. Insider selling also drew attention: CFO Shelagh Glaser sold shares at $450.02 on June 12, and CEO Sassine Ghazi sold shares at $458.96 on June 15, both under pre-arranged Rule 10b5-1 trading plans. While such sales are routine, they occurred at prices substantially above where the stock currently trades. Meanwhile, institutional activity was mixed — Dimensional Fund Advisors boosted its position by 28.1%, while Harel Insurance Investments cut its stake by 99.6%.

On the positive side, Benchmark initiated coverage with a Buy rating and a $570 price target on July 15, and Goldman Sachs highlighted Synopsys as a key beneficiary of the structural chip-design engineer shortage with a $600 price target. However, these bullish calls were insufficient to counter the overwhelming selling pressure.

What Drove SNPS Stock Performance Over the Last Quarter

The broader quarterly decline reflects a market that has grown more cautious about Synopsys' post-Ansys integration trajectory. While the acquisition substantially expanded the company's total addressable market and delivered eye-catching revenue growth of approximately 42% year-over-year, reported GAAP profitability has been compressed by integration costs, amortization of acquired intangibles, and deal-related charges. GAAP net income for Q2 was just $17.1 million, versus $349.2 million a year earlier, while GAAP EPS of $0.09 contrasted sharply with the non-GAAP figure of $3.35. This wide gap between GAAP and non-GAAP results has fueled debate about the true earnings power of the combined entity.

Additionally, management's commentary around "agentic AI" — AI systems that run Synopsys software alongside human engineers — signals a potentially transformative but unproven pricing model shift. CEO Sassine Ghazi described at the Mizuho Technology Conference a future where the company charges not just for human user subscriptions but for AI agent usage as well. While strategically compelling, this transition introduces complexity into revenue visibility at a time when investors are demanding clearer evidence that the Ansys deal will deliver the promised cross-selling synergies and margin expansion. The upcoming Investor Day on September 30 is widely expected to provide more clarity on these long-term targets.

SNPS Stock Forecast Drivers: What Investors Should Watch Next

Investors will be closely monitoring Synopsys' fiscal Q3 2026 earnings, expected in late August, for evidence that the IP licensing business is stabilizing and that full-year guidance can be revised materially higher. The company's September 30 Investor Day represents a critical catalyst, where management is expected to lay out long-term financial targets and elaborate on the AI-agent pricing model and Ansys synergy roadmap. Macroeconomic risks remain salient, including potential changes to U.S. export controls affecting China-exposed revenue (approximately 10% of total sales), geopolitical instability, and the trajectory of semiconductor R&D budgets in an environment of elevated trade tensions. On the competitive front, the duopoly with Cadence Design Systems remains stable, but the growing trend of hyperscale customers building custom chips in-house could reshape demand patterns over time. Technical traders will be watching whether deeply oversold RSI readings near 22 translate into a mean-reversion rally or whether structural concerns continue to drive price discovery lower.

Using AI Tools in My Research Process

During volatile stretches like this one for SNPS, I have found it helpful to review automated strategies for additional context. Tickeron’s Trending AI Robots page highlights top-performing bots with distinct strategies and performance metrics, offering a practical way to explore data-driven approaches that align with different investment objectives.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: SNPS

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SNPS in downward trend: price may decline as a result of having broken its higher Bollinger Band on August 07, 2026

SNPS broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 36 similar instances where the stock broke above the upper band. In of the 36 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SNPS as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for SNPS moved below the 200-day moving average on July 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNPS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SNPS entered a downward trend on July 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SNPS's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for SNPS just turned positive on July 31, 2026. Looking at past instances where SNPS's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNPS advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SNPS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.499) is normal, around the industry mean (22.706). P/E Ratio (91.046) is within average values for comparable stocks, (70.701). Projected Growth (PEG Ratio) (2.136) is also within normal values, averaging (2.165). SNPS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (8.403) is also within normal values, averaging (111.934).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNPS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Twilio (NYSE:TWLO), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 33.88B. The market cap for tickers in the group ranges from 48.8K to 3.59T. MSFT holds the highest valuation in this group at 3.59T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was -2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 19%. WETO experienced the highest price growth at 216%, while YYAI experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was -60%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 71
Price Growth Rating: 55
SMR Rating: 79
Profit Risk Rating: 91
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
SNPS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of software based designing solutions for the semiconductor industry

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
675 Almanor Avenue
Phone
+1 650 584-5000
Employees
28000
Web
https://www.synopsys.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Synopsys (SNPS) Stock Slides -17.8% Over 30 Days: Drivers Behind the Move and What Comes Next